SPECT Identifies Compensated Cirrhotics with Higher Accuracy than Blood Tests, John Hoefs MD, Dipu Ghosh MS, MBA, Asian Pacific Association for the Study of the Liver, 2024.
26.NASH Cirrhosis: The Intra-Hepatic Hemodynamic Abnormality (IHHA) of Cirrhosis Measured Baseline and Change Over Time Predicts Clinical Outcomes and Survival, John Hoefs MD, THE LIVER MEETING, 2023.
25.Hemodynamic Measurement of Quantitative Liver Function by HEPATIQ Detects CLD and Differentiates from Acute Causes of Jaundice, John Hoefs MD, DIGESTIVE DISEASE WEEK, 2023.24. Revolutionizing Care in Cirrhotic Patients Using HEPATIQ in a Community Setting, Thatcher Huynh, DO; Bethany Lyche; Kip Lyche, MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2022.23.HAI by HEPATIQ: Marker for ALD or for alcoholic hepatitis? John C Hoefs MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2022. 22. The functional liver volume (fLV) by HEPATIQ is superior to ATI in the diagnosis of steatohepatitis, John Hoefs MD, Society of Nuclear Medicine and Molecular Imaging Conference 2022. 21.Large Functional Liver Volume (fLV) and ATI Combined in the Diagnosis of Steatohepatitis, John Hoefs MD, DIGESTIVE DISEASE WEEK, 2022. 20.HEPATIQ Predicts Decompensation for Cirrhotics, John Hoefs MD, Dipu Ghosh MS, MBA, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2021. 19.HEPATIQ Predicts Cirrhosis and Decompensation, John Hoefs MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2021. 18.Quantitative Liver Spleen Scan Can Predict the Outcome in Patients with Alcoholic Hepatitis, M.A. Hashim, M.S. Ismail, W.H. Moore, M.M. Hassan, J. Hoefs & P. Jalal, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2020. 17.Is Physiologic Staging of Chronic Liver Disease Possible with Ultrasound? John Hoefs MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2020. 16.Liver Surface Nodularity as an Estimate of Quantitative Liver Function and Portal Hypertension, John Hoefs MD, DIGESTIVE DISEASE WEEK, 2020.15.Quantitative Hepatic Function Predicts Time to Death After Diagnosis of Hepatocellular Carcinoma (HCC), John Hoefs MD, DIGESTIVE DISEASE WEEK, 2020.14.Small Liver Volumes: Cause and Significance, John Hoefs MD, The Liver Meeting, HEPATOLOGY, October 2019.13. Physiologic Staging with Hepatiq Predicts Cirrhosis Better Than Shear Wave Elasticity, John Hoefs MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2018. 12.Shear Wave Elasticity (SWE) Unreliable in Detection of Cirrhosis, John Hoefs MD, American Association of the Study of Liver Diseases, THE LIVER MEETING, 2018.11.Steatohepatitis: Differential Features on Quantitative Liver-Spleen Scan (QLSS), John Hoefs MD, European Association for the Study of the Liver, THE INTERNATIONAL LIVER CONGRESS, 2017.10.Physiologic Staging in Alcoholic Liver Disease Predicts Death and Monitors Recovery, John Hoefs MD, European Association for the Study of the Liver, THE INTERNATIONAL LIVER CONGRESS, 2017.
9.HEPATIQ Measure of Hepatic Function: Range in Function for Ascites & Death in Patients with Chronic Liver Disease, Hoefs JC; Journal of Hepatology, vol. 64, S213–S424, 2016.8.Functional Elements Associated with Hepatic Regeneration in Living Donors after Right Hepatic Lobectomy. Gregory T. Everson, John C. Hoefs, Claus U. Niemann, Kim M Olthoff, Robert Dupuis, Shannon Lauriski, Andrea Herman, Norah Milne, Brenda W. Gillespie, Nathan P. Goodrich and James E. Everhart; LIVER TRANSPLANTATION, Vol. 19, No. 3, 2013.7.Quantitative Liver Function Tests Improve the Prediction of Clinical Outcomes in Chronic Hepatitis C, Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, et. al.; HEPATOLOGY 2012; volume 55: pages 1019-1029.
6.Quantitative Tests of Liver Function Measure Hepatic Improvement after Sustained Virologic Response, Everson GT, Shiffman ML, Hoefs JC, et al, and the HALT-C Trial Group; Alimentary Pharmacology & Therapeutics. Vol 29, pp 589-601, 2009.5.The Spectrum of Hepatic Functional Impairment in Compensated Chronic Hepatitis C: Results from the Hepatitis C Anti-Viral Long-term Treatment against Cirrhosis Trial, Everson et al, Alimentary Pharmacology & Therapeutics, Vol 27, 2008.4.Factors Affecting the Quantitative Liver–Spleen Scan in Normal Individuals, John C. Hoefs, MD, Muhammad Y. Sheikh, MD, Heather Guerrero, and Norah Milne, MD; Digestive Diseases and Sciences, Vol. 50, No. 2, February 2005, pp. 283–289.3.A Novel, Simple Method of Functional Spleen Volume Calculation by Liver-Spleen Scan, John Hoefs MD et al., Journal of Nuclear Medicine, Vol 40, No. 10, October 1999.2.Functional Measurement of Nonfibrotic Hepatic Mass in Cirrhotic Patients, John Hoefs MD et al, American Journal of Gastroenterology, Vol 92, November 1997.1. Perfused Kupffer Cell Mass: Correlation with Histology and Severity of Chronic Liver Disease, John Hoefs MD, et al, Digestive Diseases and Sciences, Vol 40, No. 3, March 1995.